Unlock instant, AI-driven research and patent intelligence for your innovation.

Chinese patent drug for treating asthma

A technology of Chinese patent medicine and asthma, which is applied in the direction of drug combination, medical formula, medical preparations containing active ingredients, etc., and can solve the problems of easy rebound of asthma, large toxic and side effects, and difficult to cure asthma

Active Publication Date: 2014-05-14
广东泰康制药有限公司
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Currently available drugs on the market are difficult to cure asthma. Once the drug is stopped, asthma tends to rebound, and the side effects are relatively large.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Chinese patent drug for treating asthma
  • Chinese patent drug for treating asthma

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0011] The present invention uses 800 cases, each oral capsule or pill 0.5g, three times a day, swallow with warm boiled water after meals, and take it for 2-3 weeks, it has a good effect on asthma, and the symptoms of asthma all have after one week Very good relief, no toxic side effects occur in any case. After taking the medicine so far, there has been no rebound phenomenon at least half a year, and as many as more than a year.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a Chinese patent drug for treating asthma. The Chinese patent drug is characterized by comprising 25g of rhizoma arisaematis, 15g of inula flower and 10g of radix ranunculi ternati according to compatibility weight radio. The materials are porphyrized and stirred evenly to be made into 100 capsules, 0.5g capsules or pills is taken orally easy time, the Chinese patent drug is taken three times one day, swallowed with the warm boiling water after a meal and is taken continuously for 2-3 weeks, and has good effect for asthma.

Description

1. Technical field [0001] The invention relates to a traditional Chinese medicine compound oral capsule, in particular to a Chinese patent medicine for treating asthma. 2. Background technology [0002] Asthma is a common chronic disease, and it is one of the common chronic diseases clinically. It is characterized by recurrent sitting, and the interval between attacks is normal. Currently commercially available medicines are difficult to cure asthma. Once the medicine is stopped, asthma tends to rebound, and the side effects are relatively large. Therefore seek a kind of can alleviate the pain for asthmatic patient, the Chinese medicine compound preparation with little toxic and side effects becomes urgent task. 3. Contents of the invention [0003] The technical problem to be solved by the present invention is to overcome the deficiencies in the prior art and provide a Chinese patent medicine that can relieve the pain of asthma patients and has little toxic and side effe...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/8884A61P11/06
Inventor 胡宝山刘广博
Owner 广东泰康制药有限公司